CLDX - Celldex Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - In Vitro & In Vivo Diagnostic Substances - CLDX (744218)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
8 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2025-12-04
CLDXJimenez Freddy A.SVP, GCS - Sale$29.10-4,16630,796-12%-$121,210
D
2025-11-13
CLDXWright Richard M.Former OfficerS - Sale+OE$24.00-49,29820,833-70%-$1,183,177
2025-08-13
CLDXJimenez Freddy A.SVP, GCS - Sale$24.77-77134,962-2%-$19,096
2024-11-11
CLDXMarucci Anthony SPres, CEOP - Purchase$26.82+11,50040,284+40%+$308,430
D
2024-06-14
CLDXMartin Samuel BatesSVP, CFOS - Sale+OE$35.42-17,17228,125-38%-$608,315
D
2024-06-14
CLDXCrowley ElizabethSVP, CPDOS - Sale+OE$34.87-30,0009,074-77%-$1,045,962
D
2024-06-07
CLDXCrowley ElizabethSVP, CPDOS - Sale+OE$35.06-15,0009,074-62%-$525,873
2024-06-07
CLDXYoung Diane C.SVP, Chief Medical OfficerS - Sale$35.26-45,0002,115-96%-$1,586,844

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top